BlackRock Group’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$5.71M Sell
194,922
-108,210
-36% -$2.95M ﹤0.01% 1117
2016
Q3
$8.24M Sell
303,132
-2,975
-1% -$67.3K ﹤0.01% 969
2016
Q2
$5.71M Buy
306,107
+23,751
+8% +$495K ﹤0.01% 1045
2016
Q1
$7.64M Sell
282,356
-2,117
-0.7% -$60.7K ﹤0.01% 980
2015
Q4
$8.57M Buy
284,473
+15,844
+6% +$508K ﹤0.01% 958
2015
Q3
$8.5M Buy
268,629
+10,342
+4% +$378K 0.01% 961
2015
Q2
$10.1M Buy
258,287
+29,625
+13% +$1.02M 0.01% 969
2015
Q1
$8.1M Buy
228,662
+47,562
+26% +$1.53M ﹤0.01% 1012
2014
Q4
$5.71M Buy
181,100
+6,000
+3% +$166K ﹤0.01% 1090
2014
Q3
$3.92M Sell
175,100
-164,104
-48% -$3.29M ﹤0.01% 1172
2014
Q2
$7.45M Buy
+339,204
New +$6.45M ﹤0.01% 1024

Other funds holding PAHC

BlackRock Group's PAHC Position: Q4 2016 in Review

BlackRock Group reduced its Phibro Animal Health (PAHC) stake by 36% in Q4 2016, selling an estimated $2.95M and leaving 194,922 shares worth $5.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

BlackRock Group first reported a position in PAHC in Q2 2014 and has held it in 11 quarters since. The position peaked at $10.1M in Q2 2015. 143 funds tracked by Wall St. Rank hold PAHC as of Q4 2016.

  • BlackRock Group held 194,922 shares of Phibro Animal Health worth $5.71M as of Q4 2016.
  • BlackRock Group sold 108,210 Phibro Animal Health shares in Q4 2016, an estimated $2.95M.
  • Phibro Animal Health made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1117 holding.
  • BlackRock Group first reported a position in Phibro Animal Health in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Group's Phibro Animal Health position peaked at $10.1M in Q2 2015.
  • 143 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.